Loading...
XJPX
2931
Market cap295mUSD
Jul 10, Last price  
345.00JPY
1D
0.29%
1Q
-14.18%
Jan 2017
-73.21%
IPO
108.84%
Name

Euglena Co Ltd

Chart & Performance

D1W1MN
XJPX:2931 chart
P/E
P/S
0.95
EPS
Div Yield, %
Shrs. gr., 5y
6.25%
Rev. gr., 5y
16.68%
Revenues
50.37b
+5.78%
3,046,348,0003,046,348,0005,924,356,0005,924,356,00011,103,230,00011,103,230,00013,886,603,00013,886,603,00015,174,582,00015,174,582,00013,967,671,00013,967,671,00013,317,316,00013,317,316,00023,291,848,00027,536,309,60044,392,000,00046,482,000,00047,618,000,00050,370,000,000
Net income
-805m
L+23.85%
118,177,000118,177,000469,639,000469,639,000673,344,000673,343,000785,886,000785,886,000-1,252,194,000-1,252,194,000-9,798,460,000-9,798,561,000-1,486,498,000-1,486,686,000-3,227,952,000-4,031,152,800-2,672,000,000-2,653,000,000-650,000,000-805,000,000
CFO
5.19b
+96.14%
201,033,000250,538,00086,174,000163,544,000-7,806,000620,966,000913,588,000153,756,000-1,238,020,0001,089,392,000-1,217,472,0001,378,499,000924,000,000658,000,0002,645,000,0005,188,000,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Euglena Co., Ltd. is a Japanese enterprise specializing in the research, development, cultivation, and marketing of microalgae. Its operations are structured around two primary divisions: Healthcare Business and Energy/Environment Business. The company manufactures and sells a variety of euglena-derived food items and cosmetics. Additionally, it offers a broad portfolio of consumer goods, such as health foods, beverages, confectionery, and sports nutrition products. Furthermore, Euglena is engaged in pioneering biofuel and environmental technologies leveraging microalgae, and it makes strategic investments in the biotechnology sector. Its merchandise is distributed through numerous retail channels, including convenience stores, pharmacies, grocery stores, beauty parlors, and various specialty retailers. The company was established in Tokyo, Japan, in 2005.
IPO date
Dec 20, 2012
Employees
865
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122021‑092020‑122020‑092019‑122019‑092018‑122018‑092017‑122017‑092016‑122016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT